About aptorum group ltd - APM
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.
APM At a Glance
Aptorum Group Ltd.
17 Hanover Square
London, Greater London W1S 1BN
| Phone | 44-20-8092-9299 | Revenue | 0.00 | |
| Industry | Pharmaceuticals: Major | Net Income | -1,363,270.00 | |
| Sector | Health Technology | Employees | 2 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
APM Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 0.373 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.83 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | -2.335 |
APM Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -681,635.00 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
APM Liquidity
| Current Ratio | 0.782 |
| Quick Ratio | 0.782 |
| Cash Ratio | 0.752 |
APM Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -7.83 |
| Return on Equity | -6.162 |
| Return on Total Capital | -5.118 |
| Return on Invested Capital | -6.16 |
APM Capital Structure
| Total Debt to Total Equity | 15.237 |
| Total Debt to Total Capital | 13.222 |
| Total Debt to Total Assets | 18.843 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | N/A |